Skip to main content
PLOS One logoLink to PLOS One
. 2021 Feb 5;16(2):e0245093. doi: 10.1371/journal.pone.0245093

A multidimensional functional fitness score has a stronger association with type 2 diabetes than obesity parameters in cross sectional data

Pramod Patil 1, Poortata Lalwani 2, Harshada Vidwans 3, Shubhankar Kulkarni 1, Deepika Bais 3, Manawa Diwekar-Joshi 3, Mayur Rasal 1, Nikhila Bhasme 1, Mrinmayee Naik 1, Shweta Batwal 1, Milind Watve 1,*
Editor: Antonio Palazón-Bru4
PMCID: PMC7864668  PMID: 33544739

Abstract

Objectives

We examine here the association of multidimensional functional fitness with type 2 diabetes mellitus (T2DM) as compared to anthropometric indices of obesity such as body mass index (BMI) and waist to hip ratio (WHR) in a sample of Indian population.

Research design and method

We analysed retrospective data of 663 volunteer participants (285 males and 378 females between age 28 and 84), from an exercise clinic in which every participant was required to undergo a health related physical fitness (HRPF) assessment consisting of 15 different tasks examining 8 different aspects of functional fitness.

Results

The odds of being diabetic in the highest quartile of BMI were not significantly higher than that in the lowest quartile in either of the sexes. The odds of being a diabetic in the highest WHR quartile were significantly greater than the lowest quartile in females (OR = 4.54 (1.95, 10.61) as well as in males (OR = 3.81 (1.75, 8.3). In both sexes the odds of being a diabetic were significantly greater in the lowest quartile of HRPF score than the highest (males OR = 10.52 (4.21, 26.13); females OR = 10.50 (3.53, 31.35)). After removing confounding, the predictive power of HRPF was significantly greater than that of WHR. HRPF was negatively correlated with WHR, however for individuals that had contradicting HRPF and WHR based predictions, HRPF was the stronger predictor of T2DM.

Conclusion

The association of multidimensional functional fitness score with type 2 diabetes was significantly stronger than obesity parameters in a cross sectional self-selected sample from an Indian city.

Introduction

Contrary to the classical belief, it is being increasingly clear that actual evidence for obesity being the main, central and causal factor for insulin resistance and type 2 diabetes mellitus (T2DM) is quite weak and debated [1]. Many shortcomings and paradoxes in this view are becoming apparent with increasing research. (i) The direction of causality between obesity, insulin resistance and hyperinsulinemia is debated. While the classical view presumes obesity to be primary, giving rise to insulin resistance and hyperinsulinemia as a compensatory response of the body, an upcoming view is that hyperinsulinemia has a causal role in obesity [25]. Downregulation of insulin expression by insulin gene dosage [6], pharmaceutical suppression of insulin [7] or fat cell specific insulin receptor knockouts [8] protect against obesity. Epidemiological evidence is predominantly associative and does not clearly show causal relationship of obesity with insulin resistance and hyperinsulinemia. (ii) The association between obesity and insulin resistance is quantitatively quite weak throughout the globe with the median variance explained being only about15% across published studies [9]. Classes of individuals that are normal weight but metabolically obese [10] and obese but metabolically normal [11] are well known and are not rare by any standard. Individual metabolic responses to a given level of obesity have a large variance the reasons for which are not clearly known [12]. (iii) Further, the association varies between populations, normal weight T2DM being more common in south Asians [13, 14]. (iv) As a result of the emphasis on obesity, little guidelines for preventive interventions for the normal weight metabolically obese individuals are available [10].

The definition of obesity and the reliability of measurable indices is also debated. Body mass index (BMI) is perhaps the most commonly used index, but its limitations have been well recognized [15]. Estimates of total body fat do not consistently improve the association with insulin resistance than the anthropometric measures across studies [9, 16, 17]. The distribution of fat is claimed to be different in the metabolically healthy obese [12]. However, why the distribution of fat varies between individuals is not clearly known. It is certainly not explained by energy balance alone and therefore there is little guidance for effective intervention to improve fat distribution.

Given the limitations of obesity and its anthropometric indicators as predictors of T2DM, one needs to look for alternative and more reliable predictors. There have been arguments and evidence about fitness being more important than fatness [1825]. However, most studies have looked at a single dimension of fitness such as grip strength [21, 22], lower body strength [24, 25] or cardiorespiratory fitness [1821]. Most of these studies find that some form of functional fitness has a protective role against T2DM and many other life-style related disorders. However, fitness is a multidimensional concept which is difficult to capture in a single task performance test. Whether a multidimensional fitness score has greater predictive power than a single dimension or single task has not been addressed seriously. Currently there is no standardized set of test protocols for assessing multidimensional functional fitness. We found an opportunity to examine multidimensional fitness score as a predictor of T2DM using retrospective data from an exercise clinic in Pune, India, which routinely conducted a multidimensional fitness test at entrance for every new participant. We used this opportunity to make a preliminary assessment of whether a comprehensive index of fitness gives us a cross-sectional predictability substantially greater than that given by obesity parameters. Despite the limitations of being a retrospective study, the results are suggestive of a major conceptual change.

Methods

The clinic and the patient group

Deenanath Mangeshkar Hospital and Research Centre, a multi-speciality hospital in Pune city, India, opened an exercise clinic namely BILD (behavioural intervention for lifestyle disorders) clinic in 2017. It serves as an exercise training centre for prevention as well as treatment for neuro-orthopedic, metabolic and endocrine problems. The exercise prescription is personalized depending upon the problem addressed along with the capacity and physical limitations of the individual. In order to record the capacity and limitations of the patients, the centre conducts a routine health related physical fitness (HRPF) examination of every entrant. HRPF is a multidimensional functional fitness test consisting of 15 small tasks that examine different dimensions of physical fitness including abdominal plasticity, balance, endurance, flexibility, nerve-muscle coordination, muscle strength, core strength and agility. The set, described in the [S1 File], gives a differential score to each of the fitness components and a total composite fitness score. The HRPF protocol has been standardized at this clinic to serve the purpose of assessing the physical capacity of an entrant before prescribing any exercise regime. During past one year the clinic had performed over 800 HRPF assessments covering age groups between 18 and 84. We noted that type 2 diabetics in the sample ranged between ages 28 and 84 and therefore we used the same range for the non-diabetic counterpart of the sample. This resulted in the selection of 285 males and 378 females out of which 81 males and 69 females were type 2 diabetic (Table 1).

Table 1. The age sex characteristics and the mean HRPF score with and without age correction.

Diabetic Non-diabetic
Males Sample size 81 204
Age range 33–84 28–80
Age mean (stddev) 59.91 (10.74) 47.38 (11.99)
BMI (stddev) 26.2 (3.45) 26.89 (3.64)
WHR (stddev) 0.976 (0.049) 0.947 (0.046)
HRPF score mean (stddev) 46.71 (15.37) 63.91 (12.8)
Age corrected HRPF 49.92 (8.95) 103.4 (10.68)
Females Sample size 69 309
Age range 28–76 28–80
Age mean (std dev) 56.43 (10.6) 44.49 (11.06)
BMI (std dev) 28.37 (4.23) 28.2 (5.15)
WHR (std dev) 0.922 (0.067) 0.87 (0.07)
HRPF score mean (std dev) 39.95 (13.56) 55.5 (13.04)
Age corrected HRPF (std dev) 42.66 (8.02) 89.14 (11.01)

The nature of the study was retrospective. The study proposal was reviewed by the Institutional Ethics Committee, In-house Research, of the DeenanathMangeshkar Hospital and Research Centre. The committee approved the study and owing to the retrospective nature, the requirement for informed consent was waived by the committee and the data were anonymized before availing for analysis which was done between October to December 2018.

Statistics used

We used Pearson’s correlation to examine the interrelationship between different fitness components and their relationship with age and obesity parameters. Bonferroni correction was applied to use a conservative significance level since multiple correlations were being performed. Since T2DM is an age related disorder and since age had a significant negative correlation with fitness, age corrected fitness scores were used for further analysis.

The male and female populations were divided into quartiles according to HRPF, individual fitness components, BMI and WHR. We looked at the odds ratios in males and females separately as well as in the pooled data. For pooling male female data, males and females were ranked separately, quartiles identified separately and then pooled together. Odds of being a diabetic were calculated for each of the quartiles. Odds ratio (OR) between the 1st and 4th quartiles was used as a cross sectional predictor. For the functional fitness components the odds of being diabetic were expected to be higher in the lowest quartile therefore the ratio of first to forth quartile was expressed. In the case of BMI and WHR, odds in the fourth quartile were expected to be higher and therefore the ratio was expressed as forth to first quartile. The significance of difference between odds ratios was tested by z transformation of log OR difference using the standard errors of OR.

To examine whether the best or the worst fitness components contributed more to the association between HRPF and T2DM, we ranked individuals for each functional fitness component independently. We then added the 3 highest and 3 lowest ranking scores of every individual and looked at odds of being diabetic across their quartiles.

Results

The age distribution of the diabetics in both sexes was negatively skewed and that in the non-diabetics was positively skewed. Therefore although we matched the age range, the mean age of diabetics was greater than that for non-diabetics in both the sexes (Table 1). Therefore for all further analysis we take every variable after correcting for age according to the regression in the data pooled for diabetics and non-diabetics.

BMI did not correlate with age significantly in either of the sexes (males r = -0.136, NS; females r = 0.085, NS). In both sexes WHR correlated positively with age (males r = 0.287, p < .001; females r = 0.227, p<0.001). In males, the HRPF score decreased with age but the rate of decrease was significantly steeper in diabetics (r2 = 0.451 and regression slope = – 0.961, CI = – 0.72 to– 1.28) than non-diabetics (r2 = 0.342, slope = – 0.625, CI = – 0.505 to– 0.74). The pattern was similar in females but the difference in the slopes was not significant (diabetics r2 = 0.342 and slope = – 0.747, CI = – 0.531 to –1.03)) (non-diabetics r2 = 0.296, slope = – 0.642, CI = – 0.523 to– 0.7451)). Nevertheless the best fit regression line for diabetics lay below that for non-diabetics throughout the age range indicating that at any age group diabetics were functionally less fit than non-diabetics (Fig 1).

Fig 1.

Fig 1

Age trend in HRPF scores in diabetics (dark circles) and non-diabetics (hollow squares) with respect to HRPF scores (A) males (B) females.

The different components of functional fitness were intercorrelated positively but the r2values were small, over 95% of them ranging between 0.00001 and 0.25 with occasional outliers going up to 0.42 (Fig 2). The components were significantly positively correlated to the total score as expected in both sexes and the component that explained maximum variance in HRPF was muscle strength (63.2% in males and 40.3% in females).

Fig 2.

Fig 2

(A) males (B) females: clustering of different components of functional fitness based on the pair wise coefficients of determination, using nearest neighbor clustering. Note that most coefficients are below 0.3 with the exception of balancing and muscle strength in females. Thus no single component represents overall fitness very well.

After correcting for age, HRPF score was not correlated with BMI either in diabetics or non-diabetics in both sexes. But BMI was negatively correlated with some of the components of functional fitness namely abdominal plasticity (r = – 0.187, p <0.001) and core strength (r = – 0.247, p < 0.001) in females, balance (in males r = – 0.323, p < 0.001 and in females– 0.430, p < 0.0001) and muscle strength (in males r = – 0.233, p< 0.001; in females r = – 0.409 p <0.001) in both sexes. WHR was significantly negatively correlated with age corrected HRPF (males r = – 0.231, p< 0.001; females r = – 0.239, p< 0.001). Although statistical significance was seen, the coefficients of determination in both the cases were very small (0.052 and 0.057). BMI was not significantly correlated with WHR in both sexes. Thus neither BMI nor WHR reflected on functional fitness very well.

The odds of finding a diabetic in the lowermost quartile of BMI was significantly greater than that in the highest quartile, contrary to the expectation in males (OR = 0.41 (0.19, 0.89); but not in females OR = 0.65 (0.31, 1.37)) (Fig 3). The odds of being a diabetic in the highest WHR quartile were significantly greater than the lowest quartile in females (OR = 4.54 (1.95, 10.61)) as well as in males (OR = 3.81 (1.75, 8.3)). In both sexes the odds of being a diabetic were significantly greater in the lowest quartile of HRPF score than the highest (males OR = 10.52 (4.21, 26.13); females OR = 10.50 (3.53, 31.35)). In both sexes the ORs for HRPF were over two fold those of the corresponding ORs for WHR but the differences were not statistically significant. However when data on the two sexes were pooled with nested ranking, the OR for HRPF (OR = 9.78 (4.93, 19.8)) was significantly greater than the OR for WHR (4.03 (2.09, 7.08); p one tailed = 0.03). Therefore the predictive power of HRPF appears to be greater than WHR and BMI.

Fig 3. Odds of being type 2 diabetic among quartiles of different components of functional fitness in comparison with morphometric indices.

Fig 3

Males- orange bars, females–blue bars.

The odds ratios of the lowest to highest quartiles of some of the individual fitness component scores (Fig 3) were also significant. However the ORs of individual fitness components were lower than that for the total HRPF score and not significantly different from each other (Fig 4). The only exception was nerve-muscle coordination in males (OR = 16.63 (6.36, 35.6)) for which the OR was greater than the OR for HRPF but the difference was not significant. However it was significantly greater than the OR for WHR (p one tailed 0.019). The predictive power of the multidimensional functional fitness generally appeared to be better than most of the single task scores or single dimensions of functional fitness.

Fig 4. The ORs across first and 4th quartile for being diabetic and their confidence intervals for different fitness dimensions, collective HRPF and morphometric parameters.

Fig 4

A: males, B: females.

Since WHR and HRPF were good predictors of diabetes but not BMI, we tested whether WHR and HRPF were independent predictors. After correcting for WHR, HRPF remained a significant predictor although the odds ratio decreased in males (OR = 5.05 (2.33, 10.98)) but increased in females (OR = 22.3 (6.59, 75.5)). Reciprocally after correcting for HRPF, WHR remained a significant predictor with a marginal decrease in odds ratios (males 3.766 (1.7, 8.37); females (2.58 (1.18, 5.63)). This indicates that both WHR and HRPF are independent predictors. Moreover after removing the confounding the OR for HRPF in females was significantly greater than OR for WHR (p one tailed 0.0015). Also with both sexes pooled, the difference was statistically significant (p one tailed = 0.0068). Thus with or without confounding, multidimensional functional fitness score appears to have a greater predictive value than the obesity parameters BMI and WHR.

Since WHR and HRPF are independent predictors of T2DM, one would expect maximum risk for individuals with unfavorable fitness score as well as unfavorable WHR. Simultaneously it would be enlightening to see the risk for individuals that have favorable functional fitness but unfavorable WHR, or favorable WHR but unfavorable functional fitness. Since the correlation between WHR and HRPF was weak, it was possible to find individuals in the fourth quartile of WHR which is most unfavorable for health but the most favorable (forth) quartile of HRPF and vice versa. When the proportion of diabetics in the four combinations were plotted (Fig 5) the maximum incidence (32 out of 59) was in the most unfavorable HRPF as well as most unfavorable WHR classes as expected, and lowest (only 2 out of 44) in the diametrically opposite combination. This indicates that the effects of WHR and HRPF are synergistic. However it can be seen that the gradient across HRPF was much sharper than the gradient across WHR. Furthermore in the combination where WHR was unfavorable and HRPF was favorable, the incidence was only 1 out of 18, but when HRPF was unfavourable and WHR was favourable it was 12 out of 31. So when cases in which the two predictors were in opposite direction, HRPF was a better quantitative predictor than WHR.

Fig 5. The proportion of diabetic people along the first and forth quartiles of WHR and HRPF.

Fig 5

As expected, the proportion in the lowest HRPF and highest WHR quartiles is the largest and highest HRPF and lowest WHR quartiles the smallest. Particularly notable pattern is that individuals that have good HRPF scores had low incidence even when WHR was bad. On the other hand when WHR was good but HRPF bad, the incidence was substantially higher. Pooled data on both sexes where ranking is done separately in males and females.

In order to examine whether the association between lower HRPF scores and T2DM is dominated by the weaker components of fitness or the stronger ones, we ranked all individuals according to each of the component fitness scores and then for each individual totaled the lowermost and uppermost three ranks. The index thus obtained for the weaker dimensions of fitness was a much better predictor of T2DM, the odds ratio for males being OR = 13.4 (4.84, 37.14) and for females OR = 19.51 (4.47, 84.3). On the other hand the index for the three strongest components had a relatively lower predictive power, OR for males being 8.52 (3.06, 23.76); females 4.64 (2.06, 10.4)). The difference between ORs of weakest and strongest components was statistically significant for females (p one tailed 0.039), for males it was not statistically significant but the direction of change was similar. This suggests that weakest fitness dimensions appear to influence the association more than the strongest fitness dimensions for any individual.

Since we observed from the data that there was a significant association between low fitness score and T2DM, we tried to address the question whether diabetes leads to progressive decline of fitness or whether loss of fitness was a predisposing factor for diabetes. The age related decline in HRPF was faster in diabetics than in non-diabetics in males but not in females as shown earlier. If diabetes leads to progressive loss of fitness, we would expect people with longer duration of diabetes to have lower fitness scores. Among the individuals in the sample, data on duration of diabetes was available for 52 males and 38 females. In this subsample, we did find a significant negative correlation between HRPF and duration of diabetes in males (r = –0.38, p = 0.01). However, after correcting for age the correlation was lost. On the contrary, the age-HRPF negative correlation was not lost after correcting for duration of diabetes (corrected r = – 0.569, p = 0.01). This suggests that the apparent negative correlation of HRPF with duration of diabetes is likely to be contributed by age alone. In females, on the other hand, there wasn’t a significant correlation between HRPF and duration of diabetes (r = – 0.237, p > 0.05). Therefore the prediction of the hypothesis that diabetes leads to a progressive loss of fitness was not supported by data. Although the causal relation cannot be ascertained from this analysis alone, its inability to support progressive effect of diabetes on fitness makes it more likely that loss of fitness predisposes to diabetes.

Discussion

The central finding of the study is that the multidimensional fitness score was a substantially better predictor of T2DM as compared to BMI and WHR in a cross sectional sample of the Indian population. Our study was retrospective and was not a randomized sample from the population. Nevertheless there is no apparent reason why a self-selection bias would lead to lower fitness scores in diabetics as compared to non-diabetics. The study is certainly indicative and should be followed up with prospective studies with better sampling design. The HRPF protocol used was not intended to be a predictor of diabetes. But since we find it to be of substantial potential interest, it might be possible to refine, standardize and validate the index further for use as a diabetes risk factor. Thus although our study has the limitations of a retrospective study, the possible implications can be potentially important for the prevention of type 2 diabetes.

The different dimensions of functional fitness such as balance, endurance, flexibility, nerve-muscle coordination, muscle strength, core strength and agility captured by component fitness scores were correlated positively with each other but the correlations were weak. This means that the different components of fitness are unlikely to be represented well by a single test or measurement. Fitness is necessarily a multidimensional concept and only anthropometry or a single task performance does not reflect on overall fitness sufficiently well. In particular, BMI and WHR were poorly correlated with the functional fitness components and therefore are unlikely to be good surrogates of overall fitness. Among individuals with an impairment such as osteoarthritis, anthropometric indices may have a stronger correlation with loss of functional fitness [26, 27] but these associations in terms or OR or HR are substantially weaker than those between HRPF and T2DM found in this study [28, 29]. Therefore it is unlikely that function fitness association with T2DM is because of obesity.

The question whether any particular single component of fitness is a better predictor of T2DM needs to be kept open since we did not find a significant difference in their predictive ability in terms of OR. Nevertheless almost all single components had ORs smaller than the total score which indicates the importance of multidimensional functional fitness score. If some component is found to be consistently the best predictor across different populations, it may become a simple and single useful test in future, but from our sample it appears that it is necessary to look collectively at different dimensions of fitness.

The exercise of taking the lowermost and uppermost scores suggests, on the other hand, that rather than a single component, an individual’s weakest fitness components appear to determine the risk of being diabetic. This means that a balanced and all round fitness needs to be emphasized and only being normal weight or strong in one or two components may not be sufficient. Different types of exercises have differential emphases on particular fitness components. Therefore rather than one particular type of monotonous exercise, diversity of exercises strengthening different components of functional fitness is likely to be a more successful preventive measure. This is an interesting possibility raised by this study which needs more research to explore its translational importance.

The study exposes the extremely limited role of obesity parameters in T2DM either as causal or simply correlated variables. Particularly since south Asia is known to have a substantial number of normal weight type 2 diabetics, it is necessary to move the focus from obesity to better correlated, and if possible demonstrably causal factors. Sarcopenia is a known predisposing factor for insulin resistance [30, 31] which would be reflected in some components of the fitness tests. However in our study balance, endurance and nerve muscle coordination were also good predictors of T2DM without necessarily being highly correlated with muscle strength. Therefore it is possible that apart from fat and muscle mass, a number of other functional fitness parameters play a role. Other signals such as EGF, BDNF, FGF, other growth factor signals [3237], autonomic neuronal signals [38], myokines [3941], muscle damage, pain and infection [4244] have been shown to affect insulin sensitivity partly or completely independent of obesity. Therefore it is necessary to look beyond obesity parameters as risk factors and potentially causal factors.

Why should low functional fitness be associated with T2DM? In evolutionary medicine a number of novel hypotheses for the origin of T2DM have been suggested. The classical thrifty gene [45] and thrifty phenotype [46] hypotheses are obesity centered. There are alternative hypotheses based on behavioural and reproductive strategies or life-history strategies [4749] which are not obesity centered, although they might allow a correlation with obesity. In these hypotheses, physical strength, social ranking and thereby reproductive opportunities play a more important role than obesity. A definite role of brain and neuronal circuits is being highlighted by a number of recent studies [5052]. In an ancestral environment, physical fitness is expected to play a role in deciding behavioural and reproductive strategies and therefore a change in metabolic and neuroendocrine make up may follow loss of physical fitness. For example, a physically weak individual is most likely to be a subordinate individual in a primate social hierarchy and accordingly needs to change its foraging, social and reproductive strategies [53, 54]. The position in social hierarchy might be lost by the loss of one or more components of fitness. Here the weaker components are likely to matter more than the stronger components. The strategic changes required on being weak are accompanied by metabolic, endocrine and immunological fine tuning [5255]. Although the relationship between physical fitness and social hierarchy has changed in the modern human society, human physiology is still likely to be responding according to the evolved ancestral optimization. This is the potential theoretical underpinning of the significant association between functional fitness and T2DM.

Our finding, if confirmed across populations, has important clinical implications. While the prevention and treatment for obesity is based on improving energy balance, the treatment does not specifically address fat distribution. On the other hand specific exercises can be designed to improve the deficient components of fitness specifically. Such a strategy needs to be explored with further focused research.

Conclusion

In a retrospective study of the Indian population loss of functional fitness was found to have a significantly greater association with type 2 diabetes than the anthropometric parameters of obesity or central obesity. Functional fitness is a multidimensional concept and the association of the multidimensional fitness score appeared to be stronger than most of the individual fitness components. The study indicates that loss of any of the functional dimensions might contribute to this association. Although this study does not ascertain the causal relationship, we did not find support to the hypothesis that diabetes progressively led to loss of fitness, keeping the possibility open that loss of fitness may predispose to diabetes.

Declarations

Ethics approval and consent to participate: This was a retrospective study with data available on the clinic record, so consent of participants is not relevant.

Consent for publication: All authors and the Hospital authorities have their consent to publish.

Availability of data and materials: Details of the HRPF assessment and the datasets analyzed during the current study are available from the corresponding author on reasonable request.

Supporting information

S1 File. Protocol for conducting and scoring HRPF.

(DOCX)

S1 Data

(XLSX)

List of abbreviations

BMI

Body Mass Index

WHR

Waist hip ratio

HRPF

Health related physical fitness

T2DM

Type2 diabetes mellitus

OR

Odds Ratio

NS

Non Significant

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.World Health Organization, Global Report on Diabetes. Technical report 21 April 2016. http://www.who.int/diabetes/global-report/en/ [Google Scholar]
  • 2.Chakravarthy MV, Zhu Y, Wice MB, Coleman T, Pappan KL, Marshall CA, et al. Decreased Fetal Size Is Associated With β-Cell Hyperfunction in Early Life and Failure With Age. Diabetes. 2008;157(10): 2698–707 10.2337/db08-0404 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Pories WJ, Dohm GL. Diabetes: Have We Got It All Wrong?: Hyperinsulinism as the culprit: surgery provides the evidence. Diabetes Care. 2012;35(12): 2438–42 10.2337/dc12-0684 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Corkey BE. Banting Lecture 2011: Hyperinsulinemia: Cause or Consequence? Diabetes.2012;61(1):4–13. 10.2337/db11-1483 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Shanik MH, Xu Y, Skrha J, Dankner R, Zick Y, Roth J. Insulin Resistance and–Hyperinsulinemia: Is hyperinsulinemia the cart or the horse? Diabetes Care.2008; January;31(Supplement 2):S2 62–8. 10.2337/dc08-s264 [DOI] [PubMed] [Google Scholar]
  • 6.Templeman N, Clee S, James J. Suppression of hyperinsulinaemia in growing female mice provides long-term protection against obesity. Diabetologia.2015; 58(10): 2392–402. 10.1007/s00125-015-3676-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Lustig R, Hinds P, Ringwald-Smith K, Christensen R, Kaste S, Schreiber R, et al. Octreotide Therapy of Pediatric Hypothalamic Obesity: A Double-Blind, Placebo-Controlled Trial. J ClinEndocrinolMetab.2003; 88(6):2586–92. 10.1210/jc.2002-030003 [DOI] [PubMed] [Google Scholar]
  • 8.Blüher M, Michael D, Peroni D, Ueki K, Carter N, Kahn B, et al. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev cell.2002; 3(1):25–38. 10.1016/s1534-5807(02)00199-5 [DOI] [PubMed] [Google Scholar]
  • 9.Vidwans HB, Watve MG. How much variance in insulin resistance is explained by obesity? J Insul Resist.2017; 27;1(1). 10.4102/jir.v2i1.22 [DOI] [Google Scholar]
  • 10.Ding C, Chan Z, Magkos F. Lean, but not healthy: the ’metabolically obese, normal-weight’ phenotype. CurrOpinClinNutrMetab Care. 2016;19(6):408–417. [DOI] [PubMed] [Google Scholar]
  • 11.Smith G, Mittendorfer B, Klein S.Metabolically healthy obesity: facts and fantasies. J Clin Invest. 2019;129(10):3978–3989. 10.1172/JCI129186 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Blüher M. Metabolically Healthy Obesity. Endocrine Reviews 2020; 41 (3): 405–420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Yoon H, Lee H, Kim JW, Cho JH, Choi YH, Ko SH, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet.2006; November;368(9548): 1681–8. 10.1016/S0140-6736(06)69703-1 [DOI] [PubMed] [Google Scholar]
  • 14.Flowers E, Lin F, Kandula NR, Allison M, Carr J, Ding J, et al. Body Composition and Diabetes Risk in South Asians: Findings From the MASALA and MESA Studies. Diabetes Care.2019; 42; (5): 946–953. 10.2337/dc18-1510 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.NuttallFQ. Body Mass Index, Nutrition Today. 2015; 50 (3): 117–128 10.1097/NT.0000000000000092 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Lee CC, Glickman SG, Dengel DR, Brown MD, Supiano MA. Abdominal adiposity assessed by dual energy X-ray absorptiometry provides a sex-independent predictor of insulin sensitivity in older adults. The Journals of gerontology. Series A, Biological Sciences and Medical Sciences. 2005; 60(7):872–877. 10.1093/gerona/60.7.872 [DOI] [PubMed] [Google Scholar]
  • 17.Sierra-Johnson J, Johnson BD, Bailey KR, Turner ST. Relationships between insulin sensitivity and measures of body fat in asymptomatic men and women. Obes Res. 2004; 12(12):2070–7. 10.1038/oby.2004.258 . [DOI] [PubMed] [Google Scholar]
  • 18.Barry VW, Baruth M, Beets MW, Liu J, Blair SN. Fitness vs. Fatness on All-Cause Mortality: A Meta-Analysis. ProgCardiovasc Dis.2014; 56(4):382–90. 10.1016/j.pcad.2013.09.002 [DOI] [PubMed] [Google Scholar]
  • 19.Ortegaa F, Cadenas-Sancheza C, Lee D, Ruiz J, Blair S, Suic X. Fitness and Fatness as Health Markers through the Lifespan: An Overview of Current Knowledge. ProgPrev Med. 2018; 3(2):10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Kennedy AB, Lavie CJ, BlairSN. Fitness or Fatness: Which Is More Important? JAMA.2018; 319(3):231–2. 10.1001/jama.2017.21649 [DOI] [PubMed] [Google Scholar]
  • 21.Lee HY, Yang HK, Song HJ, Chang HJ, Kang JY, Lee SH, et al. Metabolic health is more closely associated with decrease in lung function than obesity. PLoS One.2019; 14(1):1–14. 10.1371/journal.pone.0209575 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Cetinus E, Buyukbese MA, Uzel M, Ekerbicer H, Karaoguz A. Hand grip strength in patients with type 2 diabetes mellitus. Diabetes Res ClinPract.2005; 70(3): 278–86. 10.1016/j.diabres.2005.03.028 [DOI] [PubMed] [Google Scholar]
  • 23.Mainous AG, Tanner RJ, Anton SD, Jo A. Grip Strength as a Marker of Hypertension and Diabetes in Healthy Weight Adults. Am J Prev Med. 2015; 49(6):850–8. 10.1016/j.amepre.2015.05.025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Brito LB, Ricardo DR, Araújo DS, Ramos PS, Myers J, Araújo CG. Ability to sit and rise from the floor as a predictor of all-cause mortality.Eur J PrevCardiol. 2014;13;21(7):892–8. http://journals.sagepub.com/doi/10.1177/2047487312471759 [DOI] [PubMed] [Google Scholar]
  • 25.Van Lummel RC, Walgaard S, Maier AB, Ainsworth E, Beek PJ, Van Dieën JH. The Instrumented Sit-to-Stand Test (iSTS) Has Greater Clinical Relevance than the Manually Recorded Sit-to-Stand Test in Older Adults. Bayer A,editor.PLoS One. 2006. 8;11(7):e0157968 10.1371/journal.pone.0157968 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Gill SV, Hicks GE, Zhang Y, Niu J, Apovian CM, White DK. The association of waist circumference with walking difficulty among adults with or at risk of knee osteoarthritis: the Osteoarthritis Initiative. Osteoarthritis Cartilage. 2017;25(1):60–66. 10.1016/j.joca.2016.07.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.King LK, March L, Anandacoomarasamy A. Obesity & osteoarthritis. Indian J Med Res. 2013;138(2):185–193. [PMC free article] [PubMed] [Google Scholar]
  • 28.Reyes C, Leyland KM, Peat G, Cooper C, Arden NK, Prieto-Alhambra D. Association Between Overweight and Obesity and Risk of Clinically Diagnosed Knee, Hip, and Hand Osteoarthritis: A Population-Based Cohort Study. Arthritis Rheumatol. 2016;68(8):1869–75. 10.1002/art.39707 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Raud B., Gay C., Guiguet-Auclair C. et al. Level of obesity is directly associated with the clinical and functional consequences of knee osteoarthritis. Sci Rep 10, 3601 (2020). 10.1038/s41598-020-60587-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Srikanthan P, Hevener AL, A.S. K. Sarcopenia Exacerbates Obesity-Associated Insulin Resistance and Dysglycemia: Findings from the National Health and Nutrition Examination Survey III. Earnest CP, editor. PLoS One.2010; 26;5(5):e10805 10.1371/journal.pone.0010805 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Cleasby ME, Jamieson PM, Atherton PJ. (2016). Insulin resistance and sarcopenia: mechanistic links between common co-morbidities. J Endocrinol.2016; 229(2):R67–81. 10.1530/JOE-15-0533 [DOI] [PubMed] [Google Scholar]
  • 32.Gogg S, Smith U. Epidermal growth factor (EGF) and TGF alpha mimic the effects of insulin in human fat cells and augment down-stream signaling in insulin resistance 277: J Biol Chem. 2002; 277:36045–51. 10.1074/jbc.M200575200 [DOI] [PubMed] [Google Scholar]
  • 33.Duan W, Guo Z, Jiang H, Ware M MM. Reversal of behavioral and metabolic abnormalities and insulin resistance Syndrome, by Dietary Restriction in Mice Deficient in Brain-Derived Neurotrophic Factor. Endocrinology.2003; 144(6):2446–53. 10.1210/en.2002-0113 [DOI] [PubMed] [Google Scholar]
  • 34.Miettinen P, Ustinov J, Ormio P, Gao R, Palgi J, Hakonen E, et al. Downregulation of EGF Receptor Signaling in Pancreatic Islets Causes Diabetes Due to Impaired Postnatal β-Cell Growth. Diabetes.2006; 55(12):3299–308. 10.2337/db06-0413 [DOI] [PubMed] [Google Scholar]
  • 35.Rogers C, Moukdar F, McGee M, Davis B, Buehrer B, Daniel K, et al. EGF Receptor (ERBB1) Abundance in Adipose Tissue Is Reduced in Insulin-Resistant and Type 2 Diabetic Women. 329–40. J ClinEndocrinolMetab.2012; 97(3):329–40. [DOI] [PubMed] [Google Scholar]
  • 36.Kim H, Lee J, Cha J, Hyun Y, Kim J, Lee M, et al. Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice. Endocrinology.2013; 154(9):3366–77. 10.1210/en.2012-2276 [DOI] [PubMed] [Google Scholar]
  • 37.Meek T, Wisse B, Thaler J, Guyenet S, Matsen M, Fischer J, et al. BDNF Action in the Brain Attenuates Diabetic Hyperglycemia via Insulin-Independent Inhibition of Hepatic Glucose Production. Diabetes.2013; 62(5):1512–8. 10.2337/db12-0837 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Marino J, Xu YH. Central insulin and leptin-mediated autonomic control of glucose homeostasis.Trends EndocrinolMetab.2011; 22(7):275–85. 10.1016/j.tem.2011.03.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Eckardt K, Görgens S, Raschke S EJ. Myokines in insulin resistance and type 2 diabetes.Diabetologia 2014;57(6):1087–99. 10.1007/s00125-014-3224-x [DOI] [PubMed] [Google Scholar]
  • 40.Byunghun S, Hee-Jae K, Jinsoo K WS. Exercise-induced myokines in health and metabolic diseases.Integr Med Res.2014; 3(4):172–9. 10.1016/j.imr.2014.09.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Gamas LPaulo M, Raquel S. Irisin and myonectin Regulation in the Insulin Resistant Muscle: Implications to Adipose Tissue: Muscle Crosstalk. J Diabetes Res. 2015; 359159 10.1155/2015/359159 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.CliYki-Jarvinen H, Sammalkorpi K, Koivisto V NE. Severity, duration, and mechanisms of insulin resistance during acute infections. EndocrinolMetab.1989; 69:317–23. [DOI] [PubMed] [Google Scholar]
  • 43.Lang C. Sepsis-induced insulin resistance in rats is mediated by a b -adrenergic mechanism. Am J PhysiolEndocrinolMetab.1992; 263:703–11. [DOI] [PubMed] [Google Scholar]
  • 44.Greisen J, Juhl C, Grøfte T, Vilstrup H, Jensen T SO. Acute pain induces insulin resistance in humans. Anesthesiology.2001; 95:578–84. 10.1097/00000542-200109000-00007 [DOI] [PubMed] [Google Scholar]
  • 45.Neel J V. Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”? Am J Hum Genet. 1962; 14:353–62. [PMC free article] [PubMed] [Google Scholar]
  • 46.Hales CN, Barker DJ, Clark PM, Cox L. J, Fall C, Osmond C, et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ.1991; 26;303(6809):1019–22. 10.1136/bmj.303.6809.1019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Watve MG, Yajnik CS. Evolutionary origins of insulin resistance: a behavioral switch hypothesis. BMC Evol Biol. 2007; 7(1):61 10.1186/1471-2148-7-61 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Corbett S, McMichael S. J., Prentice A.J. Type 2 diabetes, cardiovascular disease, and the evolutionary paradox of the polycystic ovary syndrome: A fertility first hypothesis. Am J Hum Biol. 2009; 21(5):587–98. 10.1002/ajhb.20937 [DOI] [PubMed] [Google Scholar]
  • 49.Wells J, Yao P, Williams JE, Gayner R. Maternal investment, life-history strategy of the offspring and adult chronic disease risk in South Asian women in the UK. Evol Med Public Heal. 2016; (1):133–45. 10.1093/emph/eow011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Deem JD, Muta K, Scarlett JM, Morton GJ, Schwartz MW. How Should We Think About the Role of the Brain in Glucose Homeostasis and Diabetes? Diabetes.2017; 66(7):1758–65. 10.2337/dbi16-0067 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Kulkarni S, Sharda S, Watve M. Bi-stability in type 2 diabetes mellitus multi-organ signalling network. Cras-Méneur C, editor. PLoS One.2018; 2;12(8):e0181536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Shpakov AO, Derkach K V., Berstein LM. Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases. FuturSciOA. 2015;1(3):FSO25 10.4155/fso.15.23 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Watve M. Developmental plasticity: need to go beyond naïve thinking. Evol Med Public Heal. 2017; 1; (1):178–80. 10.1093/emph/eox020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Watve MG. Doves, diplomats and diabetes: a Darwinian reinterpretation of type 2 diabetes and related disorders. Springer, New York, Heidelberg, (London 2013). 10.1016/j.mehy.2013.11.002 [DOI] [Google Scholar]
  • 55.Watve M.G ., Mandani S. Why serum chemokine levels are raised in insulin resistance syndrome: An immune reversal hypothesis. Curr Sci. 2008; 95(2):171–4. [Google Scholar]

Decision Letter 0

Antonio Palazón-Bru

27 Oct 2020

PONE-D-20-22351

A multidimensional functional fitness score has a stronger association with type 2 diabetes than obesity parameters in cross sectional data

PLOS ONE

Dear Dr. Watve,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Dec 11 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Antonio Palazón-Bru, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for including your ethics statement:

'The study proposal was reviewed by the Institutional Ethics Committee, In-house

Research, of the Deenanath Mangeshkar Hospital and Research Centre on 27th Aug

2018. Owing to the retrospective nature, the requirement for informed consent was

waived by the committee and the data were anonymized before availing for analysis

which was done between October to December 2018.'                                       

a. Please amend your current ethics statement to confirm that your named institutional review board or ethics committee specifically approved this study.     

b. Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”).For additional information about PLOS ONE ethical requirements for human subjects research, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research'

3. Thank you for stating the following in the Acknowledgments Section of your manuscript:

"We thank the management of Deenanath Man geshkar Hospital and Research Center that supports the BILD clinic, Mr. Deepak Desai and Mrs. Sarita Desai for financing the study..."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

"The authors received no specific funding for this work."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

5. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Abstract

- No comments

Introduction

- The first sentence is unclear. What is the main point?

- The argument is not clearly set up. It seems that the authors argue in the first paragraph that a causal relationship between obesity and T2DM does not exist. The shift in the second paragraph to measuring fitness is abrupt.

- The authors contend that anthropometric measures of obesity are not as relevant as fitness, but no papers discussing how obesity relates to anthropometric measures are discussed in the introduction. It would be helpful for the authors to cite the research measuring anthropometrics in adults with obesity to explain why they feel that fitness is a more relevant measure (see below).

o The association of waist circumference with walking difficulty among adults with or at risk of knee osteoarthritis: the Osteoarthritis Initiative

SV Gill et al., Osteoarthritis and cartilage 25 (1), 60-66

- Overall, the introduction needs to be reworked to clearly state what the argument is.

Method

- What do the authors mean by abdominal plasticity?

- Although the authors state what areas of fitness the HRPF measures, they do not provide any details about what the 15 tasks actually are.

-

Results

- No comments

Discussion

- A significant limitation of this study is that there is no measure of percent body fat. WHR provides a rough estimate of the distribution of body fat, but a formal measure of body fat, skeletal muscle mass, etc. would provide a clearer picture about why the authors argue the limited role of anthropometric measures in understanding limitations related to obesity.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Feb 5;16(2):e0245093. doi: 10.1371/journal.pone.0245093.r002

Author response to Decision Letter 0


28 Nov 2020

Dear Editor,

Thanks for giving us the opportunity to revise.

Please find below our specific responses (in blue) to individual issues.

2. Thank you for including your ethics statement:

'The study proposal was reviewed by the Institutional Ethics Committee, In-house

Research, of the Deenanath Mangeshkar Hospital and Research Centre on 27th Aug

2018. Owing to the retrospective nature, the requirement for informed consent was

waived by the committee and the data were anonymized before availing for analysis

which was done between October to December 2018.'

a. Please amend your current ethics statement to confirm that your named institutional review board or ethics committee specifically approved this study.

b. Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”).For additional information about PLOS ONE ethical requirements for human subjects research, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research'

The ethics statement is modified accordingly and corresponding change in the form made.

3. Thank you for stating the following in the Acknowledgments Section of your manuscript:

"We thank the management of Deenanath Man geshkar Hospital and Research Center that supports the BILD clinic, Mr. Deepak Desai and Mrs. Sarita Desai for financing the study..."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

"The authors received no specific funding for this work."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

The funding mentioned earlier was not for this study, but for raising the clinic infrastructure. That mention in the acknowledgement is removed now. So the funding statement remains unchanged.

4. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

Data availability statement remains unchanged and will make the repository address available on acceptance.

5. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

Rechecked and found appropriate.

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Abstract

- No comments

Introduction

- The first sentence is unclear. What is the main point?

- The argument is not clearly set up. It seems that the authors argue in the first paragraph that a causal relationship between obesity and T2DM does not exist. The shift in the second paragraph to measuring fitness is abrupt.

The opening paragraph is reorganized in the revised MS for greater clarity.

- The authors contend that anthropometric measures of obesity are not as relevant as fitness, but no papers discussing how obesity relates to anthropometric measures are discussed in the introduction. It would be helpful for the authors to cite the research measuring anthropometrics in adults with obesity to explain why they feel that fitness is a more relevant measure (see below).

We have added a new paragraph in the introduction section with references to discuss the association and possible causation links between fat distribution, anthropometry and metabolic effects.

o The association of waist circumference with walking difficulty among adults with or at risk of knee osteoarthritis: the Osteoarthritis Initiative

SV Gill et al., Osteoarthritis and cartilage 25 (1), 60-66

Thanks for bringing this paper to our notice. Citing a few other papers along with this we have added a para in the discussion section that discusses the association between anthropometric parameters and functional fitness.

- Overall, the introduction needs to be reworked to clearly state what the argument is.

We hope in the revised and rewritten form the introduction has enhanced clarity and makes the purpose of the study clear.

Method

- What do the authors mean by abdominal plasticity?

- Although the authors state what areas of fitness the HRPF measures, they do not provide any details about what the 15 tasks actually are.

All details of the 15 tasks including abdominal plasticity are described in details in the supplementary information, which is cited in the main text in the methods section. The reviewer may have missed it.

-

Results

- No comments

Discussion

- A significant limitation of this study is that there is no measure of percent body fat. WHR provides a rough estimate of the distribution of body fat, but a formal measure of body fat, skeletal muscle mass, etc. would provide a clearer picture about why the authors argue the limited role of anthropometric measures in understanding limitations related to obesity.

In the paper describing the retrospective part of the study, data on body composition was not available. This can be included in a prospective study. Nevertheless we have added in the revised paper along with selected references a brief discussion on whether body fat is a better predictor of insulin resistance or T2DM.

Attachment

Submitted filename: response to reviewers.docx

Decision Letter 1

Antonio Palazón-Bru

22 Dec 2020

A multidimensional functional fitness score has a stronger association with type 2 diabetes than obesity parameters in cross sectional data

PONE-D-20-22351R1

Dear Dr. Watve,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Antonio Palazón-Bru, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have satisfactorily responded to the reviewers' comments. I think that the manuscript is ready to be accepted.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Acceptance letter

Antonio Palazón-Bru

25 Jan 2021

PONE-D-20-22351R1

A multidimensional functional fitness score has a stronger association with type 2 diabetes than obesity parameters in cross sectional data

Dear Dr. Watve:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Antonio Palazón-Bru

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Protocol for conducting and scoring HRPF.

    (DOCX)

    S1 Data

    (XLSX)

    Attachment

    Submitted filename: response to reviewers.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES